تصفح حسب المؤلف "Doi, Suhail Ar"
-
Is there truly an increase in risk of cardiovascular and hematological adverse events with vascular endothelial growth factor receptor tyrosine kinase inhibitors?
Furuya-Kanamori, Luis; Doi, Suhail Ar; Onitilo, Adedayo; Akhtar, Saghir ( Taylor & Francis , 2019 , Article)Recent studies have shown an increase risk of cardiovascular and hematological adverse events associated with vascular endothelial growth factor tyrosine kinase inhibitors (VEGF-TKIs). The authors hypothesize that the ... -
Validation of a risk prediction model for COVID-19: the PERIL prospective cohort study.
Mohammedain, Shahd A; Badran, Saif; Elzouki, AbdelNaser Y; Salim, Halla; Chalaby, Ayesha; Siddiqui, Mya; Hussein, Yehia Y; Rahim, Hanan Abdul; Thalib, Lukman; Alam, Mohammed Fasihul; Al-Badriyeh, Daoud; Al-Maadeed, Sumaya; Doi, Suhail Ar... more authors ... less authors ( Future Medicine , 2023 , Article)This study aims to perform an external validation of a recently developed prognostic model for early prediction of the risk of progression to severe COVID-19. Patients were recruited at their initial diagnosis at two ...